Screener
Nuvation Bio NUVB Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNet.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $258,604 | $164,086 |
| Accounts receivable, net of allowance for credit loss of $nil and $nil | 27,826 | 16,076 |
| Inventory | 19,901 | 11,411 |
| Prepaid expenses and other current assets | 13,861 | 11,536 |
| Marketable securities | 402,352 | 365,125 |
| Interest receivable on marketable securities | 3,888 | 3,285 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's accounts receivable?
- Nuvation Bio (NUVB) reported accounts receivable of $27.83M in Q2 2026.
- How has Nuvation Bio's accounts receivable changed year-over-year?
- Nuvation Bio's accounts receivable increased by 933.3% year-over-year, from $2.69M to $27.83M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Nuvation Bio's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude